TrialBMC infectious diseases2023

Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi.

Bharti Wadhwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.